Tumor suppressor properties of the splicing regulatory factor RBM10

RNA Biology

Volumn 13, Issue 4, 2016, Pages 466-472

  Hernández, Jordi ^a,b   Bechara, Elias ^a,b   Schlesinger, Doerte ^a,d   Delgado, Javier ^a,b   Serrano, Luis ^a,b,c   Valcárcel, Juan ^a,b,c  

^a CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Lung cancer; Notch; NUMB; RBM10; splicing

Indexed keywords

RNA BINDING PROTEIN; RNA BINDING PROTEIN RBM10; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; RBM10 PROTEIN, HUMAN;

ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; EXON; FEMALE; GENE MUTATION; HEK293 CELL LINE; HELA CELL LINE; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG CANCER CELL LINE; MOUSE; NONHUMAN; PROTEIN STRUCTURE; REGULATORY MECHANISM; REGULATORY RNA SEQUENCE; TUMOR XENOGRAFT; ANIMAL; MUTATION; PHYSIOLOGY; TUMOR SUPPRESSOR GENE; XENOGRAFT;

ALTERNATIVE SPLICING; ANIMALS; GENES, TUMOR SUPPRESSOR; HEK293 CELLS; HELA CELLS; HETEROGRAFTS; HUMANS; MICE; MUTATION; RNA-BINDING PROTEINS;

EID: 84963657794     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.1080/15476286.2016.1144004     Document Type: Article

References (24)

1. J.G.Blackinton, J.D.Keene. Post-transcriptional RNA regulons affecting cell cycle and proliferation. Semin Cell Dev Biol 2014; 34:44-54; PMID:24882724; http://dx.doi.org/10.1016/j.semcdb.2014.05.014
2. S.Bonnal, L.Vigevani, J.Valcarcel. The spliceosome as a target of novel antitumour drugs. Nat Rev Drug Discov 2012; 11:847-59; PMID:23123942; http://dx.doi.org/10.1038/nrd3823
3. D.Kaida, T.Schneider-Poetsch, M.Yoshida. Splicing in oncogenesis and tumor suppression. Cancer Sci 2012; 103:1611-6; PMID:22691055; http://dx.doi.org/10.1111/j.1349-7006.2012.02356.x
4. C.J.David, J.L.Manley. Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev 2010; 24:2343-64; PMID:21041405; http://dx.doi.org/10.1101/gad.1973010
5. R.Karni, E.de Stanchina, S.W.Lowe, R.Sinha, D.Mu, A.R.Krainer. The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat Struct Mol Biol 2007; 14:185-93; PMID:17310252; http://dx.doi.org/10.1038/nsmb1209
6. M.Imielinski, A.H.Berger, P.S.Hammerman, B.Hernandez, T.J.Pugh, E.Hodis, J.Cho, J.Suh, M.Capelletti, A.Sivachenko, et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 2012; 150:1107-20; PMID:22980975; http://dx.doi.org/10.1016/j.cell.2012.08.029
7. Y.Wang, A.Gogol-Doring, H.Hu, S.Frohler, Y.Ma, M.Jens, J.Maaskola, Y.Murakawa, C.Quedenau, M.Landthaler, et al. Integrative analysis revealed the molecular mechanism underlying RBM10-mediated splicing regulation. EMBO Mol Med 2013; 5:1431-42; PMID:24000153; http://dx.doi.org/10.1002/emmm.201302663
8. A.Inoue, N.Yamamoto, M.Kimura, K.Nishio, H.Yamane, K.Nakajima. RBM10 regulates alternative splicing. FEBS Lett 2014; 588:942-7; PMID:24530524; http://dx.doi.org/10.1016/j.febslet.2014.01.052
9. E.G.Bechara, E.Sebestyen, I.Bernardis, E.Eyras, J.Valcarcel. RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation. Mol Cell 2013; 52:720-33; PMID:24332178; http://dx.doi.org/10.1016/j.molcel.2013.11.010
10. S.Pece, S.Confalonieri, P.RRP, P.P.Di Fiore. NUMB-ing down cancer by more than just a NOTCH. Biochimica et Biophysica Acta 2011; 1815:26-43; PMID:20940030; http://dx.doi.org/10.1016/j.bbcan.2010.10.001
11. A.Maraver, P.J.Fernandez-Marcos, D.Herranz, M.Canamero, M.Munoz-Martin, G.Gomez-Lopez, F.Mulero, D.Megias, M.Sanchez-Carbayo, J.Shen, et al. Therapeutic effect of gamma-secretase inhibition in KrasG12V-driven non-small cell lung carcinoma by derepression of DUSP1 and inhibition of ERK. Cancer Cell 2012; 22:222-34; PMID:22897852; http://dx.doi.org/10.1016/j.ccr.2012.06.014
12. B.Westhoff, I.N.Colaluca, G.D'Ario, M.Donzelli, D.Tosoni, S.Volorio, G.Pelosi, L.Spaggiari, G.Mazzarol, G.Viale, et al. Alterations of the Notch pathway in lung cancer. Proc Natl Acad Sci U S A 2009; 106:22293-8; PMID:20007775; http://dx.doi.org/10.1073/pnas.0907781106
13. C.M.Misquitta-Ali, E.Cheng, D.O'Hanlon, N.Liu, C.J.McGlade, M.S.Tsao, B.J.Blencowe. Global profiling and molecular characterization of alternative splicing events misregulated in lung cancer. Mol Cell Biol 2011; 31:138-50; PMID:21041478; http://dx.doi.org/10.1128/MCB.00709-10
14. J.P.Orengo, D.Bundman, T.A.Cooper. A bichromatic fluorescent reporter for cell-based screens of alternative splicing. Nucleic Acids Res 2006; 34:e148; PMID:17142220; http://dx.doi.org/10.1093/nar/gkl967
15. Z.Song, P.Wu, P.Ji, J.Zhang, Q.Gong, J.Wu, Y.Shi. Solution structure of the second RRM domain of RBM5 and its unusual binding characters for different RNA targets. Biochemistry 2012; 51:6667-78; PMID:22839758; http://dx.doi.org/10.1021/bi300539t
16. G.M.Daubner, A.Clery, F.H.Allain. RRM-RNA recognition: NMR or crystallography…and new findings. Curr Opin Struct Biol 2013; 23:100-8; PMID:23253355; http://dx.doi.org/10.1016/j.sbi.2012.11.006
17. J.W.Schymkowitz, F.Rousseau, I.C.Martins, J.Ferkinghoff-Borg, F.Stricher, L.Serrano. Prediction of water and metal binding sites and their affinities by using the Fold-X force field. Proc Natl Acad Sci U S A 2005; 102:10147-52; PMID:16006526; http://dx.doi.org/10.1073/pnas.0501980102
18. S.A.Forbes, D.Beare, P.Gunasekaran, K.Leung, N.Bindal, H.Boutselakis, M.Ding, S.Bamford, C.Cole, S.Ward, et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res 2015; 43:D805-11; PMID:25355519; http://dx.doi.org/10.1093/nar/gku1075
19. I.Callebaut, J.P.Mornon. OCRE: a novel domain made of imperfect, aromatic-rich octamer repeats. Bioinformatics 2005; 21:699-702; PMID:15486042; http://dx.doi.org/10.1093/bioinformatics/bti065
20. F.Y.Zong, X.Fu, W.J.Wei, Y.G.Luo, M.Heiner, L.J.Cao, Z.Fang, R.Fang, D.Lu, H.Ji, et al. The RNA-binding protein QKI suppresses cancer-associated aberrant splicing. PLoS Genet 2014; 10:e1004289; PMID:24722255; http://dx.doi.org/10.1371/journal.pgen.1004289
21. Tessier SJ, Loiselle JJ, McBain A, Pullen C, Koenderink BW, Roy JG, Sutherland LC. Insight into the role of alternative splicing within the RBM10v1 exon 10 tandem donor site. BMC Research Notes 2015; 8:46; PMID:25889998; http://dx.doi.org/10.1186/s13104-015-0983-5
22. J.R.Tejedor, P.Papasaikas, J.Valcarcel. Genome-wide identification of Fas/CD95 alternative splicing regulators reveals links with iron homeostasis. Mol Cell 2015; 57:23-38; PMID:25482508; http://dx.doi.org/10.1016/j.molcel.2014.10.029
23. M.P.Paronetto, B.Minana, J.Valcarcel. The Ewing sarcoma protein regulates DNA damage-induced alternative splicing. Mol Cell 2011; 43:353-68; PMID:21816343; http://dx.doi.org/10.1016/j.molcel.2011.05.035
24. C.Diaz, H.Corentin, V.Thierry, A.Chantal, B.Tanguy, S.David, H.Jean-Marc, F.Pascual, B.Francoise, F.Edgardo. Virtual screening on an alpha-helix to beta-strand switchable region of the FGFR2 extracellular domain revealed positive and negative modulators. Proteins 2014; 82:2982-97; PMID:25082719; http://dx.doi.org/10.1002/prot.24657